Back to Results
First PageMeta Content
Cutaneous B-cell lymphoma / Primary cutaneous marginal zone lymphoma / Rituximab / Mycosis fungoides / Diffuse large B-cell lymphoma / Chemotherapy regimens / National Comprehensive Cancer Network / MALT lymphoma / CD20 / Lymphoma / Medicine / Oncology


NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Non-Hodgkin’s Lymphomas
Add to Reading List

Document Date: 2014-01-17 11:32:03

Open Document

File Size: 214,16 KB

Share Result on Facebook

City

Ann Arbor / Courville / /

Company

Dutch Cutaneous Lymphoma Working Group / National Comprehensive Cancer Network Inc. / Coors / PET / CBC / /

IndustryTerm

treatment of primary cutaneous follicle centre lymphoma / Therapy for Primary Cutaneous Marginal Zone Lymphoma / e-antigen / therapy for primary cutaneous B-cell lymphoma / treatment for different kinds of cutaneous lymphoma / Treatment of Cancer / Therapy for Primary Cutaneous Follicle Center Lymphoma / /

MarketIndex

NHL / /

MedicalCondition

primary cutaneous follicle centre lymphoma / progressive disease Relapsed disease / lymphoma / Contents Discussion Primary Cutaneous B-Cell Lymphomas PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA / cutaneous large-cell lymphoma / multifocal primary cutaneous B-cell lymphoma / Generalized disease / cutaneous B-cell lymphoma / Indolent primary cutaneous B-cell lymphoma / Hepatitis B / non-lymph node disease / Relapsed disease Generalized disease / Primary Cutaneous Marginal Zone Lymphoma PCFCL / Nongastric MALT Lymphoma / cutaneous B-cell lymphomas / cutaneous marginal zone Bcell lymphoma / primary cutaneous B-cell lymphoma / cutaneous diffuse large B-cell lymphoma / mycosis fungoides / progressive disease CR/PR Generalized disease / multifocal primary cutaneous marginal zone-B cell lymphoma / rituximab Generalized disease / lymphoma subtype / Sézary syndrome / B- and T-cell lymphomas / Leukemia / tumor / NK/T-Cell Neoplasms / highgrade lymphomas / cancer / disease / primary cutaneous lymphomas / Clinical trial SECONDARY THERAPY CR Observe Relapse Observe Relapse PR CR Generalized disease / Primary Cutaneous B-Cell Lymphomas / cutaneous large B-cell lymphomas / Cutaneous Lymphoma / tumor lysis syndrome / extracutaneous disease / Contents Discussion Primary Cutaneous B-Cell Lymphomas PRIMARY CUTANEOUS MARGINAL ZONE LYMPHOMA OR FOLLICLE CENTER LYMPHOMA / very extensive disease / Primary Cutaneous Follicle Center Lymphoma / Primary Cutaneous Follicle Center Lymphoma PC-DLBCL / Primary Cutaneous Marginal Zone Lymphoma / Primary Cutaneous Diffuse Large B-cell Lymphoma / Mature Be Hepatitis B / /

MedicalTreatment

polychemotherapy / combination chemotherapy / chemotherapy / radiotherapy / Radioimmunotherapy / surgical treatment / immunotherapy / drainage / /

Organization

European Organization for Research and Treatment of Cancer / Cutaneous Lymphoma Task Force / International Society for Cutaneous Lymphomas / European Organization of Research and Treatment of Cancer / American Society of Hematology / Cancer and International Society for Cutaneous Lymphoma / European Organization for Research and Treatment / Treatment of Cancer / /

Person

Arch Dermatol / Parker SR. / Ann Oncol / /

Position

RT / Regional Local RT / Jansen PM / et al / paraffin block representative / Palliative low-dose RT / pathologist / Local RT / /

Product

Guidelines Version 1 / Targretin / Guidelines 1 / /

PublishedMedium

British Journal of Dermatology / /

SportsEvent

NHL / /

Technology

chemotherapy / /

SocialTag